CBPD-268 | MedChemExpress (MCE)

CBPD-268 is a potent and orally active CBP/p300 PROTAC degrader with an DC₅₀ value of ≤ 0.03 nM. CBPD-268 induces CBP/p300 degradation and inhibits cell growth. CBPD-268 shows antitumor activity. CBPD-268 has the potential for the research of AR-positive prostate cancer (Srtucture Note: Red, Androgen receptor degrader (HY-W248665A); Blue, CBP/p300 ligand (HY-161483); Black, Linker)^[1].

Price Not Available 1 mg CBPD-268 | MedChemExpress (MCE) Supplier Page

Trivial name	CBPD-268
Catalog Number	HY-161369
Research Area	Cancer
Purity	≥98.0%
SMILES	CC(N1CC2=C(CC1)N([C@@H]3CC[C@H](CC3)CN4CC(C=C(C(N(C5CCC(NC5=O)=O)C6=O)=O)C6=C7)=C7C4)N=C2N8CCCC9=C8C=C(C(F)F)C(C%10=CN(N=C%10)C)=C9)=O
Size	1 mg
Supplier Page	https://www.medchemexpress.com/cbpd-268.html